The global infectious disease diagnostics market was worth around USD 28152.7 million in 2021 and is estimated to grow to about USD 42013.25052 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.9 percent over the forecast period.
Industry Prospective:
The global infectious disease diagnostics market was worth around USD 28152.7 million in 2021 and is estimated to grow to about USD 42013.25052 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.9 percent over the forecast period. The report analyzes the digital remittance market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital remittance market.
Infectious Disease Diagnostics Market: Overview
Infectious disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. It can be based solely on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens, and molecular methods. Diagnostic tests are crucial for diagnosing diseases and for the overall improvement of global health. Traditional methods were time-consuming and often produced inaccurate results. This led to the emergence of quick, accurate, and portable testing products in the market.
The growth of the infectious disease diagnosis market is mainly due to the increasing global prevalence of infectious diseases such as COVID-19, Ebola, Swine Flu, etc.; growing awareness for early detection using specific diagnostic tests; progress in funding for research on infectious disease diagnostics; and shift in focus from centralized laboratories to decentralized testing services.
COVID-19 Impact:
The COVID-19 pandemic had a positive impact on the infectious disease diagnostics market owing to the use of infectious disease diagnostic methods for COVID-19 testing. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement. With covid 19, people have become more conscious of infectious diseases, and responding to them has become a pressing medical issue globally. The COVID-19 pandemic has overall, stressed the healthcare systems in the world and amplified the need for the development of diagnostic instruments & diagnostic service centers. An increase in the number of COVID-19 cases coursed the demand for real-time polymerase chain reaction (RT-PCR) tests to detect COVID-19.
Infectious Disease Diagnostics Market: Growth Drivers
The global prevalence of infectious diseases and onset of COVID-19
The prevalence of infectious diseases in developed and developing regions positively influenced the growth of the infectious disease diagnostics market and is expected to be a major factor in its growth during the forecast period. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for the infectious disease diagnostics market.
Infectious Disease Diagnostics Market: Restraints
Lack of accuracy of point of care diagnostic tests and Unfavorable reimbursement scenario
In underdeveloped and low-income regions, lack of training among clinicians and poor accessibility has led to decreased adoption of Infectious Disease Diagnostics test kits. Moreover, Inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. A major challenge that most diagnostic companies face in commercializing their tests is getting health insurers to pay for them.
Infectious Disease Diagnostics Market: Segmentation
The global infectious disease diagnostics market is segregated based on product, type of testing, technology, disease type, and end-user.
By product, the global market is distinguished into Reagents, Kits, and Consumables, Instruments, and Software & Services. In 2020, the reagents, kits, and consumables segment accounted for the largest share of this market. The driving factor for the growth of this segment was the frequent purchase of these products due to their recurrent usage.
By technology, the global market is bifurcated into Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other Technologies. The immunodiagnostics segment is projected to account for the largest share. This can be attributed to the increasing use of immunoassays in COVID-19 testing, POC infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend of automation.
Report Scope:
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
Recent Developments
Regional Landscape
The infectious disease diagnostics market is dominated by North America in 2020 and is expected to dominate the market during the forecast period due to the rise in occurrence of infectious diseases, presence of key players, development of the healthcare sector, presence of national clinical laboratories, advancement in technology for diagnostic instruments in the region, and an increase in awareness among the population regarding the availability of treatment devices. However, Asia-Pacific is expected to register the highest CAGR from 2021 to 2028, owing to an increase in the prevalence of infectious diseases, a rise in demand for early diagnosis, development of healthcare infrastructure, technological advancement in diagnostic testing, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.
Competitive Landscape
Some of the main competitors dominating the global infectious disease diagnostics market include - Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland).
Global infectious disease diagnostics market is segmented as follows:
By Product
By Type of Testing
By Technology
By Disease Type
By End-User
By Region
Infectious disease is a type of disease caused by different microorganisms present in the surroundings. Infectious disease diagnostics includes different techniques, instruments, and consumables to diagnose the presence of microorganisms in the human body. The lack of sanitation and unhygienic conditions in the developing and under developing regions are the main causes for the increased prevalence of infectious disease. Due to the constant increase in the infectious diseases, most of the companies anticipate focusing on the development of in vitro diagnostics in the forecast period. Most of the infections are spread from bacteria and viruses. Bacterial infections and sexually transmitted diseases are the most common infections among others.
One of the major factors driving the growth of infectious disease diagnostics market over the forecast period is the increased prevalence of infectious disease. As per the UNAIDS report, there were around 36.7 million people in the world diagnosed with HIV/AIDS at the end of 2016 out of these, 2.1 million were children below 15 years of age. Increasing rate of infectious diseases has led to the increased adoption of molecular diagnostics over the forecast period. Moreover, increase in the government initiatives to prevent infectious disease and awareness programs are expected to promote the growth of infectious disease diagnostics market. Furthermore, market players are involved in the development of new and advanced technologies for the diagnosis of various infectious diseases at an early stage to provide better treatment. All the above factors are expected to support the growth of infectious disease diagnostics market over the forecast period. However, lack of awareness about advanced technologies and poor laboratory conditions are the major factors expected to inhibit the growth of infectious disease diagnostics market in the near future.
Infectious disease diagnostics market is segmented into product type, test type, application, and end-user. Based on product type, infectious disease diagnostics market is fragmented to consumables, instruments, and software & services. On the basis of test type, infectious disease diagnostics market is segmented into laboratory tests, an imaging test, and biopsies. Based on applications, infectious disease diagnostics market is classified into viral infection, bacterial infection, CNS infections, cardiovascular infection, GI infections, sexually transmitted disease, fungal infection, and others. Based on end users, infectious disease diagnostics market is segmented into diagnostic laboratories, contract research organization, academic and medical institutes, hospitals and surgical centers, ambulatory clinics, and home healthcare.
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa are the key regions of infectious disease diagnostics market. North America is expected to dominate the market in the forecast period which is closely followed by Europe in the near future. The Asia Pacific is the fastest growing region over the forecast period owing to the presence of developing economies. Latin America and the Middle East & Africa are expected to witness a considerable growth rate.
Some of the major players of infectious disease diagnostics market include Becton Dickinson & Company, Affymetrix, Abbott Laboratories, Cepheid Inc., BioMerieux, Hologic Inc., DiaSorin, Bio-Rad Laboratories Inc., Alere Inc., and Danaher Corporation, among others.
Request the coronavirus impact analysis across industries and markets
The prevalence of infectious diseases in developed and developing regions positively influenced the growth of the infectious disease diagnostics market and is expected to be a major factor in its growth during the forecast period. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for the infectious disease diagnostics market.
According to the Market Research report, the global infectious disease diagnostics market was worth around USD 28152.7 million in 2021 and is estimated to grow to about USD 42013.25052 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.9 percent over the forecast period.
The infectious disease diagnostics market is dominated by North America in 2020 and is expected to dominate the market during the forecast period due to the rise in occurrence of infectious diseases, presence of key players, development of the healthcare sector, presence of national clinical laboratories, advancement in technology for diagnostic instruments in the region, and an increase in awareness among the population regarding the availability of treatment devices. However, Asia-Pacific is expected to register the highest CAGR from 2021 to 2028.
Some of the main competitors dominating the global infectious disease diagnostics market include - Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland).
Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No 020-46277770
US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed